Analysis of Treatment and Prognosis in Post-Operative Patients with Urachal Carcinoma

H T Niu,P Dong,J N Wang,J Huang,Y X Zeng

DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2016.24.011

2016-01-01

Abstract:Objective Urachal carcinoma is a kind of urogenital tract malignancy with a very low incidence.The objective of this study was to observe the clinical presentation,pathological condition,treatment method and outcome of patients with urachal carcinoma.Methods A retrospective analysis of thirty-six cases of urachal carcinoma diagnosed over a period of 10 years from 2003 to 2013 was carried out.All pathologic specimens were reviewed by two separate pathologists.Clinical and histological features,treatment condition,patient follow-up and survival outcome was reviewed and calculated.Results The mean age at diagnosis was 53 years.Of the thirty-six patients,twenty-five were male.All patients underwent partial cystectomy with bilateral pelvic lymph node dissection.All cases were adenocarcinoma,including 20 mucinous adenocarcinoma,7 moderately differentiated adenocarcinoma,5 poorly differentiated adenocarcinoma,1 signet ring cell carcinoma,3 hybrid adenocarcinoma.The Sheldon pathologic stage was stage Ⅱ in 11,Ⅲ in 16 and Ⅳa in 9 cases.All patients received medical oncological therapy.The median follow-up period was 27 months.The median overall survival was 36 months.One-year survival rate was 70％ and five-year survival rate was 28％.Conclusions Urachal carcinomas are rare and usually at locally advanced stage at diagnosis with a high tendency of metastases.Surgery is a key method of primary treatment and medical oncological therapy may play a role in decreasing the chances of recurrence which still needs to be explained by prospective clinical trials.